HLA-A*0201-restricted T cells from humanized NOD mice recognize autoantigens of potential clinical relevance to type 1 diabetes

Journal of Immunology

Volumn 176, Issue 5, 2006, Pages 3257-3265

  Takaki, Toshiyuki ^a   Marron, Michele P ^b,d   Mathews, Clayton E ^c   Guttmann, Stephen T ^a   Bottino, Rita ^c   Trucco, Massimo ^c   DiLorenzo, Teresa P ^a   Serreze, David V ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b JACKSON LABORATORY   (United States)

^c CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^d University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GLUCOSE 6 PHOSPHATASE; HLA A ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; G6PC2 PROTEIN, MOUSE; HLA A*0201 ANTIGEN; HLA-A*0201 ANTIGEN; PEPTIDE FRAGMENT; PROTEIN;

ANIMAL CELL; ANTIGEN RECOGNITION; ANTIGENICITY; ARTICLE; AUTOIMMUNITY; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; IMMUNE RESPONSE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MALE; MHC GENE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TARGET CELL; ALLELE; ANIMAL; ANTIGEN PRESENTATION; BIOSYNTHESIS; CD8+ T LYMPHOCYTE; CELL CULTURE; ENZYMOLOGY; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; NONOBESE DIABETIC MOUSE; PANCREAS ISLET; T LYMPHOCYTE SUBPOPULATION; TRANSGENIC MOUSE;

ALLELES; ANIMALS; ANTIGEN PRESENTATION; AUTOANTIGENS; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DIABETES MELLITUS, TYPE 1; FEMALE; GLUCOSE-6-PHOSPHATASE; HLA-A ANTIGENS; HUMANS; ISLETS OF LANGERHANS; MALE; MICE; MICE, INBRED NOD; MICE, SCID; MICE, TRANSGENIC; PEPTIDE FRAGMENTS; PROTEINS; T-LYMPHOCYTE SUBSETS;

EID: 33644501795     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.5.3257     Document Type: Article

References (55)

1. Serreze, D. V., and E. H. Leiter. 2001. Genes and cellular requirements for autoimmune diabetes susceptibility in nonobese diabetic mice. Curr. Dir. Autoimmun. 4: 31-67.
2. Todd, J. A., and L. S. Wicker. 2001. Genetic protection from the inflammatory disease type 1 diabetes in humans and animal models. Immunity 15: 387-395.
3. null mice are diabetes and insulitis resistant. Diabetes 43: 505-509.
4. 2-microglobulin- deficient non-obese diabetic mice. Int. Immunol. 6: 1445-1449.
5. 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes 43: 500-504.
6. Katz, J., C. Benoist, and D. Mathis. 1993. Major histocompatibility complex class I molecules are required for the development of insulitis in non-obese diabetic mice. Eur. J. Immunol 23: 3358-3360.
7. a donors. Diabetes 42: 44-55.
8. DiLorenzo, T. P., R. T. Graser, T. Ono, G. J. Christianson, H. D. Chapman, D. C. Roopenian, S. G. Nathenson, and D. V. Serreze. 1998. Major histocompatibility complex class I-restricted T cells are required for all but the end stages of diabetes development in nonobese diabetic mice and use a prevalent T cell receptor α chain gene rearrangement. Proc. Natl. Acad. Sci. USA 95: 12538-12543.
9. Hattori, M., E. Yamato, N. Itoh, H. Senpuku, T. Fujisawa, M. Yoshino, M. Fukuda, E. Matsumoto, T. Toyonaga, I. Nakagawa, et al. 1999. Cutting edge: homologous recombination of the MHC class I K region defines new MHC-linked diabetogenic susceptibility gene(s) in nonobese diabetic mice. J. Immunol. 163: 1721-1724.
10. g7 complex. Diabetes 54: 1603-1606.
11. Inoue, K., H. Ikegami, T. Fujisawa, S. Noso, K. Nojima, N. Babaya, M. Itoi-Babaya, S. Makimo, and T. Ogihara. 2004. Allelic variation in class I K gene as candidate for a second component of MHC-linked susceptibility to type 1 diabetes in non-obese diabetic mice. Diabetologia 47: 739-747.
12. d is diabetogenic in the NOD mouse. Diabetes 52(Suppl. 1): A246.
13. Choisy-Rossi, C-M., T. M. Holl, M. A. Pierce, H. D. Chapman, and D. V. Serreze. 2004. Enhanced pathogenicity of diabetogenic T cells escaping a non-MHC gene-controlled near death experience. J. Immunol. 173: 3791-3800.
14. 2-microglobulin as a diabetes susceptibility gene in nonobese diabetic (NOD) mice. Proc. Natl. Acad. Sci. USA 98: 11533-11538.
15. Fennessy, M., K. Metcalfe, G. A. Hitman, M. Niven, P. A. Biro, J. Tuomilehto, and E. Tuomilehto-Wolf. 1994. A gene in the HLA class I region contributes to susceptibility to IDDM in the Finnish population. Diabetologia 37: 937-944.
16. Nejentsev, S., Z. Gombos, A. P. Laine, R. Veijola, M. Knip, O. Simell, O. Vaarala, H. K. Akerblom, and J. Ilonen. 2000. Non-class II HLA gene associated with type 1 diabetes maps to the 240-kb region near HLA-B. Diabetes 49: 2217-2221.
17. Robles, D. T., G. S. Eisenbarth, T. Wang, H. A. Erlich, T. L. Bugawan, S. R. Babu, K. Barriga, J. M. Norris, M. Hoffman, G. Klingensmith, et al. 2002. Identification of children with early onset and high incidence of anti-islet autoantibodies. Clin. Immunol. 102: 217-224.
18. Honeyman, M. C., L. C. Harrison, B. Drummond, P. G. Colman, and B. D. Tait. 1995. Analysis of families at risk for insulin-dependent diabetes mellitus reveals that HLA antigens influence progression to clinical disease. Mol. Med. 1: 576-582.
19. Nakanishi, K., T. Kobayashi, T. Murase, T. Naruse, Y. Nose, and H. Inoko. 1999. Human leukocyte anrigen-A24 and -DQA1 *0301 in Japanese insulin-dependent diabetes mellitus: independent contributions to susceptibility to the disease and additive contributions to acceleration of β-cell destruction. J. Clin. Endocrinol. Metab. 84: 3721-3725.
20. Noble, J. A., A. M. Valdes, T. L. Bugawan, R. J. Apple, G. Thomson, and H. A. Erlich. 2002. The HLA class I A locus affects susceptibility to type 1 diabetes. Hum. Immunol. 63: 657-664.
21. Tait, B. D., P. G. Colman, G. Morahan, L. Marchinovska, E. Dore, S. Gellert, M. C. Honeyman, K. Stephen, and A. Loth. 2003. HLA genes associated with autoimmunity and progression to disease in type 1 diabetes. Tissue Antigens 61: 146-153.
22. Marron, M. P., R. T. Graser, H. D. Chapman, and D. V. Serreze. 2002. Functional evidence for the mediation of diabetogenic T cell responses by HLA-A2.1 MHC class I molecules through transgenic expression in NOD mice. Proc. Natl. Acad. Sci. USA 99: 13753-13758.
23. 2m double knockout mice. J. Exp. Med. 185: 2043-2051.
24. Irwin, M., W. Heath, and L. Sherman. 1989. Species-restricted interactions between CD8 and the α3 domain of class 1 influence the magnitude of the xenogeneic response. J. Exp. Med. 170: 1091-1101.
25. + T cells in autoimmune diabetes. Proc. Natl. Acad. Sci. USA 100: 8384-8388.
26. Han, B., P. Serra, A. Amrani, J. Yamanouchi, A. F. Maree, L. Edelstein-Keshet, and P. Santamaria. 2005. Prevention of diabetes by manipulation of anti-IGRP autoimmunity: high efficiency of a low-affinity peptide. Nat. Med. 11: 645-652.
27. null mice: an immunodeficient and radioresistant model for engraftment of human hematolymphoid cells, HIV infection, and adoptive transfer of NOD mouse diabetogenic T cells. J. Immunol. 164: 2496-2507.
28. Russo, C., A. K. Ng, M. A. Pellegrino, and S. Femme. 1983. The monoclonal antibody CR11-351 discriminates HLA-A2 variants identified by T cells. Immunogenetics 18: 23-35.
29. null NOD-scid mice: an improved host for adoptive transfer of autoimmune diabetes and growth of human lymphohematopoietic cells. Diabetes 44: 1392-1398.
30. Ricordi, C., P. E. Lacy, and D. W. Scharp. 1989. Automated islet isolation from human pancreas. Diabetes 38(Suppl. 1): 140-142.
31. Lakey, J. R., G. L. Warnock, A. M. Shapiro, G. S. Korbutt, Z. Ao, N. M. Kneteman, and R. V. Rajotte. 1999. Intraductal collagenase delivery into the human pancreas using syringe loading or controlled perfusion. Cell Transplant. 8: 285-292.
32. Bottino, R., A. N. Balamurugan, S. Bertera, M. Pietropaolo, M. Trucco, and J. D. Piganelli. 2002. Preservation of human islet cell functional mass by antioxidative action of a novel SOD mimic compound. Diabetes 51: 2561-2567.
33. Ablamunits, V., D. Elias, and I. R. Cohen. 1999. The pathogenicity of islet-infiltrating lymphocytes in the non-obese diabetic (NOD) mouse. Clin. Exp. Immunol. 115: 260-267.
34. + T cell clonotype AI4. J. Immunol 173: 2530-2541.
35. Leiter, E. H. 1997. The NOD mouse: a model for insulin-dependent diabetes mellitus. In Current Protocols in Immunology. J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober, eds. John Wiley and Sons, Hoboken, pp. 15.19.11-15.19.23.
36. Karttunen, J., S. Sanderson, and N. Shastri. 1992. Detection of rare antigen-presenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens. Proc. Natl. Acad. Sci. USA 89: 6020-6024.
37. Regner, M., M. H. Claesson, S. Bregenholt, and M. Ropke. 1996. An improved method for the detection of peptide-induced upregulation of HLA-A2 molecules on TAP-deficient T2 cells. Exp. Clin. Immunogenet. 13: 30-35.
38. 2-microglobulin. J. Exp. Med. 160: 317-322.
39. b. Proc. Natl. Acad. Sci. USA 83: 7447-7451.
40. + T cell repertoires of H-2 class I wild-type/HLA-A2.1 and H-2 class I knockout/HLA-A2.1 transgenic mice. Int. Immunol. 14: 925-934.
41. Verdaguer, J., D. Schmidt, A. Amrani, B. Anderson, N. Averill, and P. Santamaria. 1997. Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice. J. Exp. Med. 186: 1663-1676.
42. + cytotoxic T cells in the destruction of pancreatic β-cells in nonobese diabetic mice. J. Immunol. 152: 2042-2050.
43. + T-cell clones in vivo. Diabetes 45: 1121-1131.
44. Amrani, A., J. Verdaguer, P. Serra, S. Tafuro, R. Tan, and P. Santamaria, 2000. Progression of autoimmune diabetes driven by avidity maturation of a T-cell population. Nature 406: 739-742.
45. Trudeau, J. D., C. Kelly-Smith, C. B. Verchere, J. F. Elliott, J. P. Dutz, D. T. Finegood, P. Santamaria, and R. Tan. 2003. Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood. J. Clin. Invest. 111: 217-223.
46. + T cell reactivity to three islet antigens, including the newly identified widely expressed dystrophia myotonica kinase. J. Immunol. 173: 6727-6734.
47. Rammensee, H.-G., J. Bachmann, and S. Stevanovic. 1997. MHC Ligands and Peptide Motifs. Landes Bioscience, Austin.
48. Nakayama, M., N. Abiru, H. Moriyama, N. Babaya, E. Liu, D. Miao, L. Yu, D. R. Wegmann, J. C. Hutton, J. F. Elliott, and G. S. Eisenbarth. 2005. Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature 435: 220-223.
49. Kent, S. C., Y. Chen, L. Bregoli, S. M. Clemmings, N. S. Kenyon, C. Ricordi, B. J. Hering, and D. A. Hafler. 2005. Expanded T cells from pancreatic lymph nodes of type I diabetic subjects recognize an insulin epitope. Nature 435: 224-228.
50. Panagiotopoulos, C., H. Qin, R. Tan, and C. B. Verchere. 2003. Identification of a β-cell-specific HLA class I restricted epitope in type 1 diabetes. Diabetes 52: 2647-2651.
51. Toma, A., S. Haddouk, J. P. Briand, L. Camoin, H. Gahery, F. Connan, D. Dubois-Laforgue, S. Caillat-Zucman, J. G. Guillet, J. C. Carel, et al. 2005. Recognition of a subregion of human proinsulin by class I-restricted T cells in type 1 diabetic patients. Proc. Natl. Acad. Sci. USA 102: 10581-10586.
52. Hassainya, Y., F. Garcia-Pons, R. Kratzer, V. Lindo, F. Greer, F. A. Lemonnier, G. Niedermann, and P. M. van Endert. 2005. Identification of naturally processed HLA-A2-restricted proinsulin epitopes by reverse immunology. Diabetes 54: 2053-2059.
53. Loirat, D., F. A. Lemonnier, and M.-L. Michel. 2000. Multiepitopic HLA-A*0201-restricted immune response against hepatitis B surface antigen after DNA-based immunization. J. Immunol. 165: 4748-4755.
54. b-β2m transgenic mice. J. Clin. Invest. 110: 453-462.
55. Graff-Dubois, S., O. Faure, D.-A. Gross, P. Alves, A. Scardino, S. Chouaib, F. A. Lemonnier, and K. Kosmatopoulos. 2002. Generation of CTL recognizing an HLA-A*0201-restricted epitope shared by MAGE-A1, -A2, -A3, -A4, -A6, -A10, and -A12 tumor antigens: implication in a broad-spectrum tumor immunotherapy. J. Immunol. 169: 575-580.